Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf is a New York Plaintiff's personal injury law firm specializing in automobile accidents, construction accidents, medical malpractice, products liability, police misconduct and all types of New York personal injury litigation.

Articles Tagged with medical malpractice lawyer

Published on:

cover of the top 10 patient safety concern ECR 2026 reportA newly released report by the ECRI and the Institute for Safe Medication Practices identifies the most serious threats to patient safety expected to impact healthcare in 2026. The annual Top 10 Patient Safety Concerns report underscores a troubling reality: despite decades of reform efforts, preventable harm remains deeply embedded in the American healthcare system.

According to the report, medical errors and other preventable adverse events cost U.S. hospitals approximately $17.1 billion every year. Another $4.6 billion annually is linked to physician burnout. When the broader consequences of unsafe care are considered, including additional treatment required after medical errors, as much as 12.6% of total healthcare spending in high-income countries may be devoted to managing the aftermath of unsafe care.

From the perspective of our New York medical malpractice attorneys, these numbers highlight a persistent systemic problem. Preventable medical errors are not rare anomalies. They often arise from failures in hospital systems, staffing, communication, and oversight.

Published on:

Elderly woman falling in hospital roomFalls with injury remain one of the most common causes of preventable harm in hospitals. Federal regulators are now placing increased scrutiny on these incidents as part of broader patient safety initiatives. New and updated reporting measures from the Centers for Medicare & Medicaid Services (CMS) are designed to improve how hospitals track, report, and ultimately prevent patient falls that lead to serious injury.

From the perspective of our medical malpractice lawyers, these measures reinforce an important principle: hospitals are expected to implement effective systems to identify patients at risk and prevent avoidable falls.

A Renewed Federal Focus on Falls With Injury

Published on:

Oure Medical malpractice ttorneys obtained a US top 5 verdict in 2025A National Look at the Biggest Medical Malpractice Verdicts of 2025

The largest medical malpractice verdicts of 2025 reflect a nationwide reckoning with the true cost of preventable medical negligence. Juries across the United States have returned extraordinary awards in cases involving catastrophic injuries, lifelong disability, and wrongful death—setting new benchmarks for accountability in healthcare.

As of now, public legal reporting has not released a newer nationwide ranking that supersedes the analysis published by Expert Institute, which remains the most comprehensive national overview of the biggest medical malpractice verdicts so far this year. That report highlights only a small number of cases that reached the highest tier nationally.

Published on:

pregnant womanThe Leapfrog Group, an independent national nonprofit focused on patient safety, has released its 2025 Maternity Care Report, providing one of the most comprehensive analyses of maternity care practices in the United States. The report draws on data from more than 2,400 hospitals, representing 80% of inpatient hospital beds nationwide, with approximately 1,700 hospitals reporting maternity care data.

As New York medical malpractice lawyers, this report reinforces a critical reality: while some progress has been made in maternity safety, serious risks remain—particularly for families delivering in states with elevated C-section rates, including New York.

What Leapfrog Measures—and Why It Matters

Published on:

visual for a podcast on Medical Malpractice Lawyer Marijo Adimey on her recent $60 million verdictMedical malpractice trials are often cast as “battles of the experts.” But in this case, Marijo C. Adimey, partner at Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf, showed that the most powerful evidence isn’t just expert testimony—it’s the story jurors can see for themselves.

Through complex imaging, careful cross-examination, and relentless preparation, Adimey proved that “the treating doctor’s note in the patient’s chart cannot be right,” leading a Nassau County jury to return a record-setting $60 million verdict in favor of her client.

Inside the Trial with Gennady Volz and Marijo C. Adimey

Published on:

 Patient with DoctorsIn a case highlighted by The New Yorker—“If A.I. Can Diagnose Patients, What Are Doctors For? Large language models are transforming medicine—but the technology comes with side effects,” by Dhruv Khullar—we’re reminded how a missed diagnosis can spiral into life-altering harm and how patients increasingly turn to A.I. for answers when medicine falls short. The story of Matthew Williams, whose cecal volvulus was initially dismissed as “constipation,” illustrates both the stakes of diagnostic error and the complicated role A.I. now plays in modern care.

In 2017, Matthew Williams went from an active life to one shaped by fear of everyday foods after an emergency visit that clinicians dismissed as “probable constipation.” A missed diagnosis of cecal volvulus—an intestinal twist that cuts off blood flow and requires urgent surgery—cost him roughly six feet of intestine, and with it the ability to eat freely, social comfort, and a measure of his former life. Years of follow-up care, repeated consultations, and dietary restrictions followed before a simple experiment with an A.I. tool helped point toward a dietary explanation that clinicians had not identified.

How a missed diagnosis becomes medical malpractice

Published on:

M Adimey Medical Malpractice (Facebook Post)Partner Marijo C. Adimey of Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf will be a panelist at the New York City Bar Association’s Medical Malpractice Conference on Friday, October 10, 2025.

She will join Hon. Tracy Catapano-Fox, Supreme Court, Queens County, and Adam Dulgacz, Heidell Pittoni Murphy & Bach, LLP, on the panel Medical Malpractice: Trial Practice. Together, they will share perspectives on trial strategy, jury dynamics, and a perspective from the bench,

Conference Overview

Published on:

Patients are at risk of technology hazardsArtificial intelligence is rapidly entering hospitals and clinics, powering devices that interpret imaging scans, assist with diagnoses, and monitor patient health in real time. While these tools hold enormous promise, a new study in JAMA Health Forum warns that many AI-enabled devices are being cleared for use without clinical validation — and those devices are significantly more likely to be recalled.

Why This Matters for Patient Safety

AI is increasingly trusted in critical areas of patient care. When these devices are rushed to market without real-world testing, the risks fall directly on patients:

Published on:

Hospitals across the country have been warned to immediately stop using certain Draeger mechanical ventilation filters after the U.S. Food and Drug Administration (FDA) issued a high-risk recall notice. The affected devices — SafeStar and TwinStar filters — are used during anesthesia and mechanical ventilation to prevent bacterial and viral contamination.

According to the FDA, the filters can cause misleading carbon dioxide readings during procedures. Carbon dioxide monitoring (capnography) is critical in surgery, particularly under anesthesia, as it helps ensure that a patient is ventilating properly. When readings are inaccurate, medical teams may administer unnecessary or harmful interventions — or fail to provide urgently needed care.

Scope of the Recall

Published on:

3D_Medical_Animation_of_Left_Atrial_Appendage_OcclusionBoston Scientific has issued updated instructions for products used in the implantation of its Watchman left atrial appendage closure device after the Food and Drug Administration (FDA) linked the procedure to 120 serious injuries and 17 patient deaths.

FDA Safety Alert Highlights Increased Risk Under Sedation

According to an FDA safety communication released on August 8, 2025, the updated instructions apply to the FXD Curve, Truseal, and Trusteer access systems—all of which are used to implant the Watchman device. The FDA warned that patients sedated but not placed on mechanical ventilation during the procedure face a heightened risk of air embolism, a dangerous condition caused when an air bubble enters the bloodstream.